Featured News
Phase 3 Demo Day highlights
December 20, 2024
Sign up for the LymeX Diagnostics Prize newsletter
More News
Phase 3 Demo Day highlights
December 20, 2024
Meet the Phase 3 teams at Demo Day
November 1, 2024
Expert support helps teams refine clinical study designs in Phase 3
October 29, 2024
Clinical laboratory subject matter experts share insights at Industry Day
September 26, 2024
Labcorp and Quest Diagnostics to support Phase 3 teams
August 22, 2024
6 teams advance to Phase 3
April 10, 2024
HHS and the Steven & Alexandra Cohen Foundation announce 5 Phase 2 winners
February 6, 2024
Judging is underway in Phase 2
October 25, 2023
HHS and the Steven & Alexandra Cohen Foundation announce the Phase 2 interim prize awards
October 4, 2023
Accelerator cohort participates in stakeholder-centered design webinar
September 25, 2023
An interview with scientific advisor Dr. Mark Soloski
August 24, 2023
An interview with scientific advisor Dr. John Aucott
August 17, 2023
An interview with scientific advisor Dr. Liz Horn
August 10, 2023
Accelerator cohort hears from patients and clinicians
August 9, 2023
HHS and the Steven & Alexandra Cohen Foundation announce $2 million in Phase 2 prizes
August 1, 2023
Competition hosts clinical utility webinar for accelerator cohort
June 13, 2023
Recognizing Lyme Disease Awareness Month 2023
May 1, 2023
How Virginia Tech is homing in on a unique molecular biomarker for Lyme disease
May 1, 2023
How Tufts University is using short-lived antibodies to identify Lyme disease infection
May 1, 2023
How T2 Biosystems Inc. is utilizing miniaturized magnetic resonance technology
May 1, 2023
How Serimmune Inc. is applying machine learning to at-home diagnostics
May 1, 2023
How Massachusetts General Hospital is utilizing genetic sequencing for diagnostics
May 1, 2023
How InBios International Inc. is using machine learning to improve disease detection
May 1, 2023
How HelixBind Inc. is translating sepsis diagnostics to Lyme disease
May 1, 2023
How George Mason University is identifying Lyme biomarkers through urine
May 1, 2023
How Drexel University College of Medicine is studying protein and sugar compounds as biomarkers
May 1, 2023
How BlueArc Biosciences Inc. is advancing low-cost diagnostics
May 1, 2023
Competition hosts FDA pre-submission webinar for accelerator cohort
April 25, 2023
Phase 2 teams learn about FDA regulatory processes
April 4, 2023
Phase 1 winners advance to 2023 LymeX Diagnostics Prize Virtual Accelerator
February 2, 2023
HHS and the Steven & Alexandra Cohen Foundation announce 10 Phase 1 winners
November 4, 2022
Judging panel assesses Phase 1 submissions
October 24, 2022
Phase 1 receives 52 submissions
September 29, 2022
Highlights from the July 13 technical webinar
July 22, 2022
Registration open: Join the July 13 technical considerations webinar
July 5, 2022
Highlights from the June 16 virtual information session
June 24, 2022
Registration open: Hear from the LymeX team at the June 16 virtual information session
May 17, 2022
Four things everyone needs to know about Lyme disease
May 17, 2022
Accelerate innovation in Lyme disease diagnostics: Enter Phase 1 of the competition
May 17, 2022
